http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6063779-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7dfd84f9157ae12c41e319ec325338d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14 |
| filingDate | 1998-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_542cd7925cf365a6e6121895826c5a93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7b529e906d1a1290503b7e486ce746f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4003375951b6bf2b8d3dbfc15bec0d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca88da3bb9f638bc85db18aba8b06772 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4d773e1c91ed239053d46719dd4e92c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28cddfb026357a3cb9a2f3a52fa0945d |
| publicationDate | 2000-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6063779-A |
| titleOfInvention | 5-(4-piperidinyl)dibenzothiazepine derivatives and 5-(4-piperidinyl)dibenzoxazepine derivatives, and antiarrhythmic agents |
| abstract | An objective of the present invention is to provide a compound that has antiarrhythmic activity. The present invention provides a compound of formula (I): wherein R1 and R2 each represent H, halogen or lower alkyl which may be substituted by halogen; A represents H, C3-6 cycloalkyl, phenyl which may be substituted by halogen, nitro, or lower alkoxy, a 5-membered or 6-membered heterocyclic ring which may contain N and/or S, -NR3R4 (wherein R3 and R4 each represent H or lower alkyl which may be substituted by phenyl), or COR5 (wherein R5 represents OH, amino or lower alkoxy); Q represents S or O; m represents 0-18; and n represents 0-2, and pharmaceutically acceptable salts and solvates thereof. |
| priorityDate | 1997-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 235.